58.81
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? - TradingView
Virus Diagnostics Market Demonstrates A Spectacular Growth - openPR.com
Director Makes Bold Move with Major Hologic Stock Purchase - TipRanks
Hologic's (NASDAQ:HOLX) Solid Earnings Are Supported By Other Strong Factors - Yahoo Finance
Hologic outlines Q3 2025 revenue target of $1B-$1.01B amid breast health recovery - MSN
Unlocking the Gonorrhea Diagnostic Market: Future Demand, Top - openPR.com
HPV and Pap Testing Market Grows Amid Cervical Cancer Screening Awareness | Roche, Hologic, Qiagen - openPR.com
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
Hologic drops as tariffs and geopolitics lead to guidance cut - MSN
Hologic: Soft Performance, But Cheap Enough (NASDAQ:HOLX) - Seeking Alpha
Mizuho cuts Hologic stock price target to $65 from $75 - Investing.com Australia
Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries - AboutLawsuits.com
Mizuho cuts Hologic stock price target to $65 from $75 By Investing.com - Investing.com South Africa
Myomectomy Market Strengthens with Rise in Uterine Fibroid - openPR.com
BioZorb Lawsuit LawyerBreast Biopsy Marker RecallApril 2025 Update - Levin Papantonio
Hologic (HOLX) Faces Lower Price Target Amidst Maintained Rating | HOLX Stock News - GuruFocus
Lobbying Update: $210,000 of HOLOGIC INC. lobbying was just disclosed - Nasdaq
Hologic (HOLX) Price Target Reduced by Morgan Stanley Analyst | HOLX Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Hologic to $65 From $77, Keeps Equalweight Rating - marketscreener.com
Hologic Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Call Transcript - Insider Monkey
Hologic stock price target cut to $65 by Jefferies - Investing.com South Africa
Breaking Down Hologic: 10 Analysts Share Their Views - Benzinga
Hologic Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hologic (HOLX) Price Target Lowered by RBC Capital | HOLX Stock News - GuruFocus
Hologic (HOLX) Target Price Lowered by Raymond James | HOLX Stock News - GuruFocus
Hologic sees drop in sales and tariff impact on stock price - Radiology Business
Leerink Partners Adjusts Hologic Price Target to $60 From $65 - marketscreener.com
Jefferies Adjusts Hologic Price Target to $65 From $78 - marketscreener.com
Hologic Enters Oversold Territory (HOLX) - Nasdaq
Hologic falls after 2025 profit forecast cut - TradingView
Hologic (HOLX) Shares Plunge 18% After Revised Earnings Outlook - GuruFocus
Evercore ISI Group Lowers Price Target for Hologic (HOLX) to $62 - GuruFocus
Evercore ISI Group Lowers Price Target for Hologic (HOLX) to $62 | HOLX Stock News - GuruFocus
Hologic (HOLX): Price Target Reduced Amid Tariff Pressures | HOL - GuruFocus
Hologic (HOLX): Price Target Reduced Amid Tariff Pressures | HOLX Stock News - GuruFocus
RBC Cuts Price Target on Hologic to $70 From $75, Keeps Sector Perform Rating - marketscreener.com
Hologic (HOLX) Receives Hold Rating from Needham Analyst | HOLX Stock News - GuruFocus
Hologic stock drops after guidance cut (HOLX:NASDAQ) - Seeking Alpha
HOLOGIC INC SEC 10-Q Report - TradingView
Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down - Yahoo Finance
Hologic Inc (HOLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - Yahoo Finance
Hologic shares fall 3% as Q2 guidance disappoints By Investing.com - Investing.com Nigeria
Hologic Inc (HOLX) Q2 Earnings: Revenue Hits $1,005.3M, Non-GAAP EPS at $1.03, Surpassing Estimates - GuruFocus
Hologic Exceeds Revenue Guidance Amid Challenges - TipRanks
Hologic: Fiscal Q2 Earnings Snapshot - MySA
Hologic Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hologic Q2’25 slides: Mixed results amid long-term growth strategy - Investing.com India
Earnings call transcript: Hologic beats Q1 2025 EPS forecast amid stock dip - Investing.com Nigeria
Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty - TradingView
Hologic Posts Q2 Loss On Impairment Charges Despite Stable Revenue - Nasdaq
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):